Skip to content

Clinical trials

Completed Atherosclerosis trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Russia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20081
20092
20112
20123
20182
20191
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
I.M. Sechenov First Moscow State Medical University3
Institute for Atherosclerosis Research, Russia2
Bayer1
CSL Behring1
Eurasian Association of Therapists1
Medtronic Endovascular1
Novartis Pharmaceuticals1
Resverlogix Corp1
Russian Cardiology Research and Production Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis18
Cardiovascular Diseases6
Coronary Artery Disease5
Acute Coronary Syndrome3
Coronary Disease3
Heart Diseases3
Peripheral Arterial Disease3
Stroke3
Carotid Artery Diseases2
Heart Failure2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.